The Radiology Business Journal (8/11) reported that while “breast MRI is often used to evaluate newly diagnosed breast cancers...there is some evidence that suggests this practice can lead to delayed surgical treatment.” Research on 189 women diagnosed with and treated for breast cancer found “that the median time to treatment was 32 days for patients who received pretreatment breast MRI and 34.5 days for patients whodid not receive pretreatment breast MRI.” Meanwhile, “even when a second lesion was discovered during the MRI, leading to an additional biopsy, it ‘did not indicate any significant delayed surgical treatment.’” The findings were published in the Journal of the American College of Radiology.
Medwire News (8/15, Cowen) reports “partial-breast and reduced-dose radiotherapy are noninferior to the whole-breast equivalent for the prevention of local relapse in women with early breast cancer,” according to a study published in The Lancet. Researchers alsofound that “women receiving partial-breast radiotherapy reported fewer adverse events, including changes in breast appearance and breast hardness, than those receiving whole-breast radiotherapy.”
Aunt Minnie (8/3, Yee) reports full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) produced comparable breast density measurements and median radiation dose values for dense breasts, according to a study published in Academic Radiology. The study’s lead researcher said that the results were evidence that radiologists could trust DBT for patients with dense breasts.